Predicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation With [18F] Fluorothymidine Positron Emission Tomography: A Pilot Study A total of 1,206 adult ...
Ilaris (canakinumab) is a brand-name prescription medication. The Food and Drug Administration (FDA) has approved it to treat certain periodic fever conditions and certain types of Still’s disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback